Latest News
Nvidia's Stock Is Completely Mispriced
Nvidia Corporation's stock is up roughly 20% over the last 12 months, while revenue grew 85% and non-GAAP EPS grew 140%, a disconnect that leaves the shares mispriced. Q1 FY27 delivered $81.6B in reve
NANO-X DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important August 11 Deadline in Securities Class Action - NNOX
New York, New York--(Newsfile Corp. - August 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nano-X Imaging Ltd. (NASDAQ: NNOX) between March 31,
ZILLOW DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zillow Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - Z, ZG
New York, New York--(Newsfile Corp. - August 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A or Class C common stock of Zillow Group, Inc. (NASDAQ: ZG)
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages PROCEPT BioRobotics Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PRCT
NEW YORK, Aug. 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between Februar
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Datavault AI Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DVLT
New York, New York--(Newsfile Corp. - August 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Datavault AI I
UL Solutions Q2 Earnings Call Highlights
UL Solutions NYSE: ULS reported second-quarter 2026 revenue growth and record adjusted EBITDA, citing demand tied to electrification, automation, product innovation and AI data-center infrastructure.
UMH Properties Q2 Earnings Call Highlights
UMH Properties NYSE: UMH reported higher second-quarter earnings and operating results, driven by rental income growth, increased occupancy and record manufactured-home sales, while maintaining its fu
USA Compression Partners Q2 Earnings Call Highlights
USA Compression Partners NYSE: USAC reported higher second-quarter revenue and maintained its full-year financial outlook as the company continued integrating the J-W acquisition, expanded its fleet p
US Foods Q2 Earnings Call Highlights
US Foods NYSE: USFD reported record second-quarter adjusted EBITDA and margin, supported by accelerating growth with independent restaurants, healthcare and hospitality customers, while reaffirming it
USANA Health Sciences Q2 Earnings Call Highlights
USANA Health Sciences NYSE: USNA said its core nutritional business remained in line with expectations during the second quarter of 2026, while near-term challenges at its Hiya and Rise Wellness ventu
U.S. Physical Therapy Q2 Earnings Call Highlights
U.S. Physical Therapy NYSE: USPH reported second-quarter 2026 revenue growth supported by higher patient volumes, improved reimbursement rates and the early rollout of hospital-affiliation agreements,
Universal Technical Institute Q3 Earnings Call Highlights
Universal Technical Institute NYSE: UTI reported higher third-quarter revenue, student enrollment and new student starts, while lowering its fiscal 2026 outlook to reflect softer-than-expected fourth-
Unitil Q2 Earnings Call Highlights
Unitil NYSE: UTL reported second-quarter 2026 adjusted net income of $5.2 million, or $0.29 per share, while reaffirming its full-year adjusted earnings guidance of $3.20 to $3.36 per share. The regul
Universal Q1 Earnings Call Highlights
Universal NYSE: UVV reported lower revenue and a net loss in the first quarter of fiscal 2027, as slower customer purchasing in an oversupplied leaf tobacco market and continued pressure in its ingred
The Economy No Longer Stinks - But Stocks Have Already Sprinted Ahead
Stocks, led by the S&P 500 and Nasdaq 100, have surged on renewed institutional risk appetite, with high-beta names outperforming. My proprietary 'Smells Funny Index' signals economic weakness is bott
Market euphoria has gone too far, banking giant warns it's time to cut risks
Bank of America is warning that market euphoria has reached levels that could leave investors vulnerable to a pullback, with its proprietary sentiment gauge approaching an extreme reading last seen in
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAPR
New York, New York--(Newsfile Corp. - August 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Capricor Thera
Palantir: Competition Is For Losers (Rating Upgrade)
Palantir is upgraded to Strong Buy following blowout Q2 earnings and accelerating revenue growth. Q2 revenue surged 93% YoY and 19% QoQ, with a Rule of 40 score at an exceptional 155, reinforcing PLTR
Aflac: Reliable Dividend Compounder, Premium Justified, But Meaningful Upside Unlikely
Aflac remains a quality dividend compounder, but its premium valuation suggests potential near-term underperformance. Recent earnings showed slowing growth, with revenue and EPS both declining year-ov
SMCI's Q4 Has To Address A $14B Cash Hole (Earnings Preview)
Super Micro Computer's revenue surged 72% YTD, but margins compressed and operating cash flow hit –$7.56B, revealing a business scaling faster than its ability to convert profits into cash. Working ca